doi:10.48130/mpb-0026-0004

[1]

Zhou ZQ. 2006. Taxonomy, geographic distribution and ecological habitats of tree peonies. Genetic Resources and Crop Evolution 53:11−22

doi: 10.1007/s10722-005-0778-y

[2]

Ekiert H, Klimek-Szczykutowicz M, Szopa A. 2022. Paeonia × suffruticosa (moutan peony)—a review of the chemical composition, traditional and professional use in medicine, position in cosmetics industries, and biotechnological studies. Plants 11:3379

doi: 10.3390/plants11233379

[3]

National Health Commission of the People's Republic of China. 2002. The notice on further standardizing the management of health food ingredients. 000013610/2002-01896. https://zwfw.nhc.gov.cn/kzx/zcfg/xspylsp_237/200202/t20020228_1316.html

[4]

Chinese Pharmacopoeia Commission. 2020. Pharmacopoeia of the People's Republic of China. Beijing: China Medical Science Press. pp. 179 https://ydz.chp.org.cn/#/main

[5]

Zhang X, Zhai Y, Yuan J, Hu Y. 2019. New insights into Paeoniaceae used as medicinal plants in China. Scientific Reports 9:18469

doi: 10.1038/s41598-019-54863-y

[6]

Yan S, Wei C. 2025. The influence of cultural experience in botanic garden on plant conservation: a case from the peony garden in China. Conservation Science and Practice 7:e70118

doi: 10.1111/csp2.70118

[7]

Wang Y, Sun M, Zhu W, Chen L, Zhu S, et al. 2025. Advances in the study of senescence mechanisms in the genus Paeonia. Horticulture Research 12:uhae344

doi: 10.1093/hr/uhae344

[8]

Yan Z, Chen C, Xie X, Fu B, Yang X. 2012. Rapid screening and quantification of sulfonate derivatives in white peony root by UHPLC–MS–MS. Analytical and Bioanalytical Chemistry 402:2173−2182

doi: 10.1007/s00216-011-5643-6

[9]

Zhao QL, Yang PW, Qian DW, Bian XK, Wang YF, et al. 2021. 不同炮制和干燥方法对白芍成分的影响及评价 [Effects of different processing and drying methods on components in Paeoniae Radix Alba and their evaluation]. 中国中药杂志 [China Journal of Chinese Materia Medica] 46:5839−5847 (in Chinese)

doi: 10.19540/j.cnki.cjcmm.20210319.303

[10]

Zheng W, Li Y, Wu X, Yuan L. 2025. Moutan Cortex: a review of origins, phytochemical characterization strategies, and anti-fibrosis-related pharmacological mechanisms and applications. Planta Medica 2025:1−19

doi: 10.1055/a-2706-7513

[11]

Pan KY. 1995. The analysis of distribution pattern in the Paeoniaceae and its formation. Journal of Systematics and Evolution 33:340−349

[12]

Hong DY, Pan KY. 1999. Taxonomical history and revision of Paeonia sect. Moutan (Paeoniaceae). Acta Phytotaxonomica Sinica 37:351−368

[13]

He CN, Peng Y, Zhang YC, Xu LJ, Gu J, et al. 2010. Phytochemical and biological studies of Paeoniaceae. Chemistry & Biodiversity 7:805−838

doi: 10.1002/cbdv.200800341

[14]

Tsai CY, Kapoor M, Huang YP, Lin HH, Liang YC, et al. 2016. Synthesis and evaluation of aminothiazole-paeonol derivatives as potential anticancer agents. Molecules 21:145

doi: 10.3390/molecules21020145

[15]

Fu PK, Wu CL, Tsai TH, Hsieh CL. 2012. Anti-inflammatory and anticoagulative effects of paeonol on LPS-induced acute lung injury in rats. Evidence‐Based Complementary and Alternative Medicine 2012:837513

doi: 10.1155/2012/837513

[16]

Chou TC. 2003. Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia. British Journal of Pharmacology 139:1146−1152

doi: 10.1038/sj.bjp.0705360

[17]

Chen B, Ning M, Yang G. 2012. Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats. Molecules 17:4672−4683

doi: 10.3390/molecules17044672

[18]

Lau CH, Chan CM, Chan YW, Lau KM, Lau TW, et al. 2007. Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. Phytomedicine 14:778−784

doi: 10.1016/j.phymed.2007.01.007

[19]

Yin J, Wu N, Zeng F, Cheng C, Kang K, et al. 2013. Paeonol induces apoptosis in human ovarian cancer cells. Acta Histochemica 115:835−839

doi: 10.1016/j.acthis.2013.04.004

[20]

Wei G, Zhang G, Li M, Zheng Y, Zheng W, et al. 2024. Panax notoginseng: panoramagram of phytochemical and pharmacological properties, biosynthesis, and regulation and production of ginsenosides. Horticulture Research 11:uhae170

doi: 10.1093/hr/uhae170

[21]

Li P, Shen J, Wang Z, Liu S, Liu Q, et al. 2021. Genus Paeonia: a comprehensive review on traditional uses, phytochemistry, pharmacological activities, clinical application, and toxicology. Journal of Ethnopharmacol 269:113708

doi: 10.1016/j.jep.2020.113708

[22]

Zhang C, Wang S, Sun J, Li X, Wang H, et al. 2024. Genome resequencing reveals the genetic basis of population evolution, local adaptation, and rewiring of the rhizome metabolome in Atractylodes lancea. Horticulture Research 11:uhae167

doi: 10.1093/hr/uhae167

[23]

Wang X, Sun K, Liao X, Zhang Y, Ban Y, et al. 2024. Physicochemical, antibacterial and aromatic qualities of herbaceous peony (Paeonia lactiflora pall) tea with different varieties. RSC Advances 14:14303−14310

doi: 10.1039/D3RA08144C

[24]

Zheng H. 2011. 艳友茶质量标准研究 [Study on the quality standard of Yanyou Tea]. 海峡药学 [Strait Pharmaceutical Journal] 23:48−50 (in Chinese)

doi: 10.3969/j.issn.1006-3765.2011.01.021

[25]

Wang F, Hu F, Zheng Z, Zhao H, An Q, et al. 2023. Extraction, purification, and component identification of monoterpene glycosides from Paeonia suffruticosa seed meal. Molecules 28:3498

doi: 10.3390/molecules28083498

[26]

Ding HY, Lin HC, Teng CM, Wu YC. 2000. Phytochemical and pharmacological studies on Chinese Paeonia species. Journal of the Chinese Chemical Society 47:381−388

doi: 10.1002/jccs.200000051

[27]

An RB, Kim HC, Lee SH, Jeong GS, Sohn DH, et al. 2006. A new monoterpene glycoside and antibacterial monoterpene glycosides from Paeonia suffruticosa. Archives of Pharmacal Research 29:815−820

doi: 10.1007/BF02973899

[28]

Ha DT, Ngoc TM, Lee I, Lee YM, Kim JS, et al. 2009. Inhibitors of aldose reductase and formation of advanced glycation end-products in Moutan Cortex (Paeonia suffruticosa). Journal of Natural Products 72:1465−1470

doi: 10.1021/np9002004

[29]

Wu J, Shen H, Xu J, Zhu LY, Jia XB, et al. 2012. Detection of sulfur-fumigated Paeoniae Alba Radix in complex preparations by high performance liquid chromatography tandem mass spectrometry. Molecules 17:8938−8954

doi: 10.3390/molecules17088938

[30]

Nie R, Zhang Y, Jin Q, Zhang S, Wu G, et al. 2021. Identification and characterisation of bioactive compounds from the seed kernels and hulls of Paeonia lactiflora Pall by UPLC-QTOF-MS. Food Research International 139:109916

doi: 10.1016/j.foodres.2020.109916

[31]

Braca A, Van Kiem P, Yen PH, Nhiem NX, Quang TH, et al. 2008. New monoterpene glycosides from Paeonia lactiflora. Fitoterapia 79:117−120

doi: 10.1016/j.fitote.2007.11.001

[32]

Ding L, Jiang Z, Liu Y, Chen L, Zhao Q, et al. 2012. Monoterpenoid inhibitors of NO production from Paeonia suffruticosa. Fitoterapia 83:1598−1603

doi: 10.1016/j.fitote.2012.09.008

[33]

Zhu X, Fang ZH. 2014. New monoterpene glycosides from the root cortex of Paeonia suffruticosa and their potential anti-inflammatory activity. Natural Product Research 28:301−305

doi: 10.1080/14786419.2013.858340

[34]

Wu SH, Luo XD, Ma YB, Hao XJ, Wu DG. 2002. Monoterpenoid derivatives from Paeonia delavayi. Journal of Asian Natural Products Research 4:135−140

doi: 10.1080/10286020290027425

[35]

Song WH, Cheng ZH, Chen DF. 2014. Anticomplement monoterpenoid glucosides from the root bark of Paeonia suffruticosa. Journal of Natural Products 77:42−48

doi: 10.1021/np400571x

[36]

Ding HY, Wu YC, Lin HC, Chan YY, Wu PL, et al. 1999. Glycosides from Paeonia suffruticosa. Chemical and Pharmaceutical Bulletin 47:652−655

doi: 10.1248/cpb.47.652

[37]

Ding L, Zhao F, Chen L, Jiang Z, Liu Y, et al. 2012. New monoterpene glycosides from Paeonia suffruticosa Andrews and their inhibition on NO production in LPS-induced RAW 264.7 cells. Bioorganic & Medicinal Chemistry Letters 22:7243−7247

doi: 10.1016/j.bmcl.2012.09.034

[38]

Wu SH, Chen YW, Yang LY, Li SL, Li ZY. 2007. Monoterpene glycosides from Paeonia delavayi. Fitoterapia 78:76−78

doi: 10.1016/j.fitote.2006.09.014

[39]

Ikuta A, Kamiya K, Satake T, Saiki Y. 1995. Triterpenoids from callus tissue cultures of Paeonia species. Phytochemistry 38:1203−1207

doi: 10.1016/0031-9422(94)00445-y

[40]

Yoshikawa M, Ohta T, Kawaguchi A, Matsuda H. 2000. Bioactive constituents of Chinese natural medicines. V. radical scavenging effect of Moutan Cortex. (1): absolute stereostructures of two monoterpenes, paeonisuffrone and paeonisuffral. Chemical and Pharmaceutical Bulletin 48:1327−1331

doi: 10.1248/cpb.48.1327

[41]

Yang RX, Zhang SW, Xue D, Xuan JH, Zhang YB, et al. 2018. Culturable endophytes diversity isolated from Paeonia ostii and the genetic basis for their bioactivity. Polish Journal of Microbiology 67:441−454

doi: 10.21307/pjm-2018-052

[42]

Yoshikawa M, Uchida E, Kawaguchi A, Kitagawa I, Yamahara J. 1992. Galloyl-oxypaeoniflorin, suffruticosides A, B, C, and D, five new antioxidative glycosides, and suffruticoside E, A paeonol glycoside, from Chinese Moutan Cortex. Chemical and Pharmaceutical Bulletin 40:2248−2250

doi: 10.1248/cpb.40.2248

[43]

Wang J, Wu G, Chu H, Wu Z, Sun J. 2020. Paeonol derivatives and pharmacological activities: a review of recent progress. Mini Reviews in Medicinal Chemistry 20:466−482

doi: 10.2174/1389557519666191015204223

[44]

Matsuda H, Ohta T, Kawaguchi A, Yoshikawa M. 2001. Bioactive constituents of Chinese natural medicines. VI. Moutan Cortex. (2): structures and radical scavenging effects of suffruticosides A, B, C, D, and E and galloyl-oxypaeoniflorin. Chemical and Pharmaceutical Bulletin 49:69−72

doi: 10.1248/cpb.49.69

[45]

Satoh K, Nagai F, Ushiyama K, Yasuda I, Seto T, et al. 1997. Inhibition of Na⁺, K⁺-ATPase by 1, 2, 3, 4, 6-Penta-O-galloyl-β-D-glucose, a major constituent of both moutan cortex and paeoniae radix. Biochemical Pharmacology 53:611−614

doi: 10.1016/S0006-2952(96)00828-3

[46]

Tanaka T, Fukumori M, Ochi T, Kouno I. 2003. Paeonianins A−E, new dimeric and monomeric ellagitannins from the fruits of Paeonia lactiflora. Journal of Natural Products 66:759−763

doi: 10.1021/np020608g

[47]

Xu SJ, Yang L, Zeng X, Zhang M, Wang ZT. 2006. Characterization of compounds in the Chinese herbal drug Mu-Dan-Pi by liquid chromatography coupled to electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry 20:3275−3288

doi: 10.1002/rcm.2717

[48]

Yang X, Li X, Zhu Y, Gao Y, Xu L. 2022. Paeoniflorin upregulates mitochondrial thioredoxin of schwann cells to improve diabetic peripheral neuropathy indicated by 4D label-free quantitative proteomics. Oxidative Medicine and Cellular Longevity 2022:4775645

doi: 10.1155/2022/4775645

[49]

Song S, Xiao X, Guo D, Mo L, Bu C, et al. 2017. Protective effects of Paeoniflorin against AOPP-induced oxidative injury in HUVECs by blocking the ROS-HIF-1α/VEGF pathway. Phytomedicine 34:115−126

doi: 10.1016/j.phymed.2017.08.010

[50]

Li L, Wang H, Zhao S, Zhao Y, Chen Y, et al. 2022. Paeoniflorin ameliorates lipopolysaccharide-induced acute liver injury by inhibiting oxidative stress and inflammation via SIRT1/FOXO1a/SOD2 signaling in rats. Phytotherapy Research 36:2558−2571

doi: 10.1002/ptr.7471

[51]

Kim MJ, Kang HH, Seo YJ, Kim KM, Kim YJ, et al. 2021. Paeonia lactiflora root extract and its components reduce biomarkers of early atherosclerosis via anti-inflammatory and antioxidant effects in vitro and in vivo. Antioxidants 10:1507

doi: 10.3390/antiox10101507

[52]

Marković T, Čutović N, Carević T, Gašić U, Stojković D, et al. 2023. Paeonia peregrina Mill petals as a new source of biologically active compounds: chemical characterization and skin regeneration effects of the extracts. International Journal of Molecular Sciences 24:11764

doi: 10.3390/ijms241411764

[53]

Parker S, May B, Zhang C, Zhang AL, Lu C, et al. 2016. A pharmacological review of bioactive constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch. Phytotherapy Research 30:1445−1473

doi: 10.1002/ptr.5653

[54]

Xin Z, Yang W, Niu L, Zhang Y. 2023. Comprehensive metabolite profile uncovers the bioactive components, antioxidant and antibacterial activities in wild tree peony leaves. International Journal of Molecular Sciences 24:10609

doi: 10.3390/ijms241310609

[55]

Zhou YX, Gong XH, Zhang H, Peng C. 2020. A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects. Biomedicine & Pharmacotherapy 130:110505

doi: 10.1016/j.biopha.2020.110505

[56]

Yun HM, Lee JY, Kim B, Park KR. 2022. Suffruticosol B is an osteogenic inducer through osteoblast differentiation, autophagy, adhesion, and migration. International Journal of Molecular Sciences 23:13559

doi: 10.3390/ijms232113559

[57]

Zhao DD, Jiang LL, Li HY, Yan PF, Zhang YL. 2016. Chemical components and pharmacological activities of terpene natural products from the genus Paeonia. Molecules 21:1362

doi: 10.3390/molecules21101362

[58]

Zhang J, Wang F, Wang H, Wang Y, Wu Y, et al. 2017. Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF-κB signaling pathways. Experimental and Therapeutic Medicine 14:5445−5451

doi: 10.3892/etm.2017.5250

[59]

Wu L, Nie L, Wang Q, Xu Z, Wang Y, et al. 2021. Comparative and phylogenetic analyses of the chloroplast genomes of species of Paeoniaceae. Scientific Reports 11:14643

doi: 10.1038/s41598-021-94137-0

[60]

He DY, Dai SM. 2011. Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine. Frontiers in Pharmacology 2:10

doi: 10.3389/fphar.2011.00010

[61]

Choi MY, Park SJ, Jeong JB. 2023. Immunostimulatory activity of Paeonia lactiflora through TLR4-dependent activation of p38, JNK, and ERK1/2 in mouse macrophages, RAW264.7 cells. Food and Agricultural Immunology 34:2222930

doi: 10.1080/09540105.2023.2222930

[62]

Yang XZ, Wei W. 2020. CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacologica Sinica 41:1387−1394

doi: 10.1038/s41401-020-00510-6

[63]

Lu Y, Wang A, Zhang J, Li L, Wei J, et al. 2019. PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Phytomedicine 64:153054

doi: 10.1016/j.phymed.2019.153054

[64]

Zhang L, Yu J, Wang C, Wei W. 2019. The effects of total glucosides of paeony (TGP) and paeoniflorin (Pae) on inflammatory-immune responses in rheumatoid arthritis (RA). Functional Plant Biology 46:107−117

doi: 10.1071/FP18080

[65]

Yang C, Cheng J, Zhu Q, Pan Q, Ji K, et al. 2023. Review of the protective mechanism of paeonol on cardiovascular disease. Drug Design, Development and Therapy 17:2193−2208

doi: 10.2147/DDDT.S414752

[66]

Lu L, Qin Y, Chen C, Guo X. 2018. Beneficial effects exerted by paeonol in the management of atherosclerosis. Oxidative Medicine and Cellular Longevity 2018:1098617

doi: 10.1155/2018/1098617

[67]

Li C, Yang L, Wu H, Dai M. 2018. Paeonol inhibits oxidized low-density lipoprotein-induced vascular endothelial cells autophagy by upregulating the expression of miRNA-30a. Frontiers in Pharmacology 9:95

doi: 10.3389/fphar.2018.00095

[68]

Yu W, Sun H, Tan Y, Zhang W. 2022. Paeoniflorin protects H9c2 cardiomyocytes against hypoxia/reoxygenation induced injury via regulating the AMPK/Nrf2 signaling pathway. Evidence-Based Complementary and Alternative Medicine 2022:7667770

doi: 10.1155/2023/9856193

[69]

Li X, Sun C, Zhang J, Hu L, Yu Z, et al. 2023. Protective effects of paeoniflorin on cardiovascular diseases: a pharmacological and mechanistic overview. Frontiers in Pharmacology 14:1122969

doi: 10.3389/fphar.2023.1122969

[70]

Motwani S, Malviya N, Goel RK, Dutt KR. 2007. Antipyretic activity of Radix paeoniae. Ancient Science of Life 27:14−18

[71]

Zhang XX, Shi QQ, Ji D, Niu LX, Zhang YL. 2017. Determination of the phenolic content, profile, and antioxidant activity of seeds from nine tree peony (Paeonia section Moutan DC.) species native to China. Food Research International 97:141−148

doi: 10.1016/j.foodres.2017.03.018

[72]

Yu M, Peng L, Liu P, Yang M, Zhou H, et al. 2020. Paeoniflorin ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition. Drug Design, Development and Therapy 14:1191−1202

doi: 10.2147/DDDT.S235207

[73]

González-Minero FJ, Bravo-Díaz L, Ayala-Gómez A. 2020. Rosmarinus officinalis L. (rosemary): an ancient plant with uses in personal healthcare and cosmetics. Cosmetics 7:77

doi: 10.3390/cosmetics7040077

[74]

Aburjai T, Natsheh FM. 2003. Plants used in cosmetics. Phytotherapy Research 17:987−1000

doi: 10.1002/ptr.1363

[75]

Tang Y, Liu Y, Luo K, Xu L, Yang P, et al. 2022. Potential applications of Lilium plants in cosmetics: a comprehensive review based on research papers and patents. Antioxidants 11:1458

doi: 10.3390/antiox11081458

[76]

Yang L, Liu S, Mu S, Guo R, Zhou L, et al. 2021. Paeoniflorin attenuates dexamethasone-induced apoptosis of osteoblast cells and promotes bone formation via regulating AKT/mTOR/autophagy signaling pathway. Evidence-Based Complementary and Alternative Medicine 2021:6623464

doi: 10.1155/2021/6623464

[77]

Guo W, Yang XG, Shi YL, Wang H. 2022. The effects and mechanism of paeoniflorin in promoting osteogenic differentiation of MC3T3-E1. Journal of Orthopaedic Surgery and Research 17:90

doi: 10.1186/s13018-022-02965-1

[78]

Mu X, Luan R, Gao Y, Zhao B, Wang J, et al. 2024. The traditional applications, phytochemistry, pharmacology, pharmacokinetics, quality control and safety of Paeoniae Radix Alba: a review. The American Journal of Chinese Medicine 52:2337−2376

doi: 10.1142/S0192415X24500897

[79]

Lee JH, Jin S, Lee MJ, Tran NKS, Kim YJ, et al. 2023. Mechanism-based biomarkers for the quality control of Dangkwisoo-san: a scoping review. Applied Biological Chemistry 66:52

doi: 10.1186/s13765-023-00802-5

[80]

Xu S, Yang L, Lin Q, Liu Z, Feng Q, et al. 2008. Simultaneous determination of paeoniflorin, albiflorin and benzoylpaeoniflorin in Radix Paeoniae Alba by TLC. Chromatographia 68:459−462

doi: 10.1365/s10337-008-0693-4

[81]

El Babili F, El Babili M, Fouraste I, Chatelain C. 2013. PEONIES: comparative study by anatomy and TLC of three traditional Chinese medicinal plants. Chinese Medicine 04:166−172

doi: 10.4236/cm.2013.44020

[82]

Wang Q, Liu R, Guo H, Ye M, Huo C, et al. 2005. Simultaneous LC determination of major constituents in red and white peony root. Chromatographia 62:581−588

doi: 10.1365/s10337-005-0660-2

[83]

Cheng Y, Peng C, Zhang H, Liu X. 2010. Structural characterization of an artefact and simultaneous quantification of two monoterpenes and their artefacts of isolation in white-peony root. Helvetica Chimica Acta 93:565−572

doi: 10.1002/hlca.200900263

[84]

Liu P, Zhang Y, Gao JY, Du MZ, Zhang K, et al. 2018. HPLC-DAD analysis of 15 monoterpene glycosides in oil peony seed cakes sourced from different cultivation areas in China. Industrial Crops and Products 118:259−270

doi: 10.1016/j.indcrop.2018.03.033

[85]

Nakaryakova NI, Bulgakova EA, Karpenko YN, Smirnova MM, Oleshko OA. 2020. Development and validation of an HPLC quantitative determination procedure for paeoniflorin in dry garden peony extract. Pharmaceutical Chemistry Journal 53:1184−1187

doi: 10.1007/s11094-020-02144-8

[86]

Ueno Y, Suzuki R, Kitamura M. 2022. ¹H-NMR-based metabolomics for the classification of the roots of Paeonia lactiflora, a constituent of kampo medicines. Chemical and Pharmaceutical Bulletin 70:859−862

doi: 10.1248/cpb.c21-01037

[87]

Dong Y, Toume K, Zhu S, Shi Y, Tamura T, et al. 2023. Metabolomics analysis of peony root using NMR spectroscopy and impact of the preprocessing method for NMR data in multivariate analysis. Journal of Natural Medicines 77:792−816

doi: 10.1007/s11418-023-01721-x

[88]

Yang S, Du QQ, Yue QX, Sun YF, Jin CS, et al. 2023. 不同品种白芍的 UPLC-Q-TOF-MS 与 HPLC 分析及评价 [Analysis and evaluation on Paeoniae radix alba from different cultivars by UPLC-Q-TOF-MS and HPLC]. 中国中药杂志 [China Journal of Chinese Materia Medica] 48:715−724 (in Chinese)

doi: 10.19540/j.cnki.cjcmm.20220618.201

[89]

Zhang L, Li DC, Liu LF. 2019. Paeonol: pharmacological effects and mechanisms of action. International Immunopharmacology 72:413−421

doi: 10.1016/j.intimp.2019.04.033